Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Inflamm Bowel Dis. 2023 Oct 3;29(10):1536-1545. doi: 10.1093/ibd/izad020.
Recent advances in the management of inflammatory bowel disease (IBD) striving for new treatment targets may have decreased rates of hospitalization for flares. We compared all-cause, IBD-related, and non-IBD-related hospitalizations while accounting for the rising prevalence of IBD.
Population-based, administrative health care databases identified all individuals living with IBD in Alberta between fiscal year 2002 and 2018. Hospitalization rates (all-cause, IBD-related, and non-IBD-related) were calculated using the prevalent Alberta IBD population. Hospitalizations were stratified by disease type, age, sex, and metropolitan status. Data were age and sex standardized to the 2019 Canadian population. Log-linear models calculated Average Annual Percentage Change (AAPC) in hospitalization rates with associated 95% confidence intervals (CIs).
From 2002-2003 to 2018-2019, all-cause hospitalization rates decreased from 36.57 to 16.72 per 100 IBD patients (AAPC, -4.18%; 95% CI, -4.69 to -3.66). Inflammatory bowel disease-related hospitalization rate decreased from 26.44 to 9.24 per 100 IBD patients (AAPC, -5.54%; 95% CI, -6.19 to -4.88). Non-IBD-related hospitalization rate decreased from 10.13 to 7.48 per 100 IBD patients (AAPC, -1.82%; 95% CI, -2.14 to -1.49). Those over 80 years old had the greatest all-cause and non-IBD-related hospitalization rates. Temporal trends showing decreasing hospitalization rates were observed across age, sex, IBD type, and metropolitan status.
Hospitalization rates are decreasing for all-cause, IBD-related, and non-IBD-related hospitalizations. Over the past 20 years, the care of IBD has transitioned from hospital-based care to ambulatory-centric IBD management.
炎症性肠病(IBD)管理方面的最新进展,追求新的治疗靶点,可能降低了 IBD 发作的住院率。我们比较了所有病因、IBD 相关和非 IBD 相关的住院情况,同时考虑到 IBD 患病率的上升。
基于人群的行政医疗保健数据库,确定了 2002 财政年度至 2018 财政年度期间艾伯塔省所有患有 IBD 的个体。使用流行的艾伯塔省 IBD 人群计算了住院率(所有病因、IBD 相关和非 IBD 相关)。住院情况按疾病类型、年龄、性别和大都市地位进行分层。数据按年龄和性别标准化为 2019 年加拿大人口。对数线性模型计算了住院率的平均年百分比变化(AAPC)及其相关 95%置信区间(CI)。
从 2002-2003 年到 2018-2019 年,所有病因的住院率从每 100 例 IBD 患者 36.57 例降至 16.72 例(AAPC,-4.18%;95%CI,-4.69 至-3.66)。IBD 相关住院率从每 100 例 IBD 患者 26.44 例降至 9.24 例(AAPC,-5.54%;95%CI,-6.19 至-4.88)。非 IBD 相关住院率从每 100 例 IBD 患者 10.13 例降至 7.48 例(AAPC,-1.82%;95%CI,-2.14 至-1.49)。80 岁以上的患者所有病因和非 IBD 相关的住院率最高。观察到随着年龄、性别、IBD 类型和大都市地位的变化,住院率呈下降趋势。
所有病因、IBD 相关和非 IBD 相关的住院率都在下降。在过去的 20 年里,IBD 的治疗已经从以医院为基础的治疗过渡到以门诊为中心的 IBD 管理。